Evelo
is a Massachusetts-based biotechnology company that researches and develops oral medicines for the treatment of patients with inflammatory diseases... Read moreEvelo
is a Massachusetts-based biotechnology company that researches and develops oral medicines for the treatment of patients with inflammatory diseases... Read more
News
Nov 24, 2023
Medthority
Evelo: Evelo Biosciences is shutting down according to a regulatory filing
Nov 22, 2023
Endpoints News
Evelo: Flagship-founded Evelo Biosciences will dissolve after finding no 'viable alternative'
Nov 22, 2023
MedCity News
Evelo: Evelo Bio Shutdown Follows a Series of Microbiome Therapy Trial Failures
Nov 22, 2023
The Business Journals
Evelo: Flagship-backed startup Evelo, behind failed eczema drug, to dissolve
Oct 18, 2023
Zacks
Evelo: Evelo (EVLO) Drops 59% on Flunking Psoriasis Drug Study
Oct 17, 2023
FinanzNachrichten
Evelo: Evelo Biosciences, Inc.: Evelo Biosciences Announces Top-Line Results From its Phase 2 Clinical Study with EDP2939 in Moderate Psoriasis
Oct 17, 2023
Nasdaq
Evelo: Evelo Biosciences: EDP2939-101 Study Fails To Meet Endpoint; To Explore Strategic Alternatives
Oct 17, 2023
Endpoints News
Evelo: Evelo dealt another blow with a PhII fail, plans for strategic alternatives
Oct 13, 2023
GlobalNewswire
Press Release: Evelo : Investor Alert: Abbott Cooper PLLC Announces Investigation into Evelo Biosciences, Inc.; Urges Evelo Stockholders to Contact Abbott Cooper Regarding Their Legal Rights
Aug 14, 2023
Citybizlist
Evelo: Evelo Biosciences Announces Second Quarter Financial Results and Recent Business Highlights
Evelo Competitors
1
2
3
4
5
6
7
8
9
10